• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Fungi (Basel) . Prevalence of COVID-19 Associated Mucormycosis in a German Tertiary Care Hospital

tetano

Editor, Senior Moderator
J Fungi (Basel)


. 2022 Mar 17;8(3):307.
doi: 10.3390/jof8030307.
Prevalence of COVID-19 Associated Mucormycosis in a German Tertiary Care Hospital


Ulrike Scharmann[SUP] 1 [/SUP], Frank Herbstreit[SUP] 2 [/SUP], Nina Kristin Steckel[SUP] 3 [/SUP], Jutta Dedy[SUP] 4 [/SUP], Jan Buer[SUP] 1 [/SUP], Peter-Michael Rath[SUP] 1 [/SUP], Hedda Luise Verhasselt[SUP] 1 [/SUP]



Affiliations

Abstract

Due to Coronavirus disease (COVID-19) a new group of patients at risk emerged with COVID-19-associated mucormycosis (CAM). Systematic studies, evaluating the prevalence of CAM are missing. To assess CAM prevalence in a tertiary care hospital in Germany, we applied direct microscopy, fungal culture and quantitative realtime in-house PCR targeting Mucorales-specific fragments of 18S and 28S rRNA on respiratory specimens of 100 critically ill COVID-19 patients. Overall, one Mucorales-PCR positive bronchoalevolar lavage was found whereas direct microscopy and fungal culture were negative in all cases. We conclude that a routine screening for CAM in Germany is not indicated.

Keywords: COVID-19; Mucorales qPCR; SARS-CoV-2; fungal infection; mucormycosis.
 
Back
Top Bottom